In early-onset T2DM, β-cell failure is the end pathophysiological stage, preceded by insulin hypersecretion which initially compensates for the increased insulin resistance mainly on the grounds of obesity, ectopic adiposity, puberty, and inflammation. This evidence concerns the gene INS and Insulin resistance.